Trending Markets Today

Today's Wisdom

"Know what you own, and know why you own it. "

— Peter Lynch

Explore Markets

Latest Market Insights

Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial

Intellia Therapeutics said its Crispr-based treatment for hereditary angioedema met its goals in a Phase 3 trial, marking a milestone for gene editing.

Read More
UK Royals head to the U.S. in the wake of war, shooting and rocky relations

The trip comes at a tricky time for the U.S. and one of its closest allies, the U.K.

Read More
Will the Iran war end supremacy of Strait of Hormuz?

The conflict has brutally exposed the energy market's Achilles heel. While global powers China, India and the EU push renewables, Gulf leaders are advancing plans for new bypass pipelines to safeguard their oil empires.

Read More
Gold Subdued Ahead Of Major Central Bank Meetings

(RTTNews) - Gold prices were little changed on Monday while the U.S. dollar index wobbled amid stalled U.S.-Iran peace talks and ahead of a slew of central bank meetings this week, with Jerome Powell holding his last press conference as Federal Reserve Chair on Wednesday.

Read More
Oil Prices Climb On Stalled Peace Talks

(RTTNews) - Oil prices climbed on Monday, extending last week's rally amid little progress in peace talks between the U.S. and Iran.

Read More
China blocks Meta's acquisition of AI startup Manus

XYZ, RROTF, MNDY/N

China said Monday it has decided to block Meta's $2 billion acquisition of Manus, a Singaporean AI startup with Chinese roots.

Read More
AI bill would crack down on deepfake distribution and protect whistleblowers

FUNC

The new measure from a key Democrat aims to take the first steps on AI regulation this year, while saving heavier lifts for later.

Read More
Europe’s rearmament push drives global military spending to record $2.9 trillion despite U.S. pullback

Global military spending rose for an 11th straight year to a record $2.89 trillion in 2025, driven by Europe’s rearmament push, even as U.S. outlays declined.

Read More
Arteris (AIP) Soars 9.9%: Is Further Upside Left in the Stock?

AIP, ALAB

Arteris (AIP) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

Read More

Academy